Failure

WELL's CRH Medical Acquires Majority Stake in Greater Washington Anesthesia

Retrieved on: 
Tuesday, August 3, 2021
Outpatient surgery, Surgery, Endoscopy, Rubber band ligation

WELL owns and operates Canada's largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multi-national multi-disciplinary telehealth offering.

Key Points: 
  • WELL owns and operates Canada's largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multi-national multi-disciplinary telehealth offering.
  • In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers.
  • To date, CRH has completed 37 anesthesia acquisitions, and now serves 77 ambulatory surgery centers in 16 states.
  • In addition, CRH owns the "CRH O'Regan System", a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids.

Ancilia Biosciences Awarded NSF Grant to Advance Platform Designed to Address Overlooked Obstacle to Success for Microbiome Therapeutics

Retrieved on: 
Tuesday, August 3, 2021
Microbiomes, Bacteriology, Environmental microbiology, Branches of biology, Bacteriophage, Biology, Gut microbiota, Organisms, Articles, Microbiome

We founded Ancilia to overcome what our researchers believe is a significant obstacle to this successthe failure to address the presence of phages that infect commensal microbiome bacteria.

Key Points: 
  • We founded Ancilia to overcome what our researchers believe is a significant obstacle to this successthe failure to address the presence of phages that infect commensal microbiome bacteria.
  • There is evidence that phages are associated with disease and that they may also compromise the efficacy of LBPs.
  • We are delighted that the NSF sees potential in our technology and is supporting further development of our platform."
  • Ancilia Biosciences ( www.anciliabio.com) is developing virus-resistant live bacterial biotherapeutics (LBPs) to alter the gut microbiome and treat disease.

Vertex CEO Reshma Kewalramani, MD to join Ginkgo Bioworks Board of Directors

Retrieved on: 
Tuesday, August 3, 2021
Plants, Reshma Kewalramani, Taxa, Ginkgo Bioworks, FASN, Ginkgo

BOSTON, Aug. 3, 2021 /PRNewswire/ -- Ginkgo Bioworks , Inc. ("Ginkgo") today announced that Reshma Kewalramani, M.D., FASN, Chief Executive Officer and President at Vertex, will join its board of directors.

Key Points: 
  • BOSTON, Aug. 3, 2021 /PRNewswire/ -- Ginkgo Bioworks , Inc. ("Ginkgo") today announced that Reshma Kewalramani, M.D., FASN, Chief Executive Officer and President at Vertex, will join its board of directors.
  • "We are honored to have Dr. Kewalramani join our board of directors.
  • "I am excited to join Ginkgo's board of directors at such a pivotal time for the company," said Reshma Kewalramani, M.D., FASN, Chief Executive Officer and President at Vertex.
  • Dr. Kewalramani plans to join as the eighth board member for Ginkgo Bioworks.

CECO Environmental Announces $5 Million Share Repurchase Program

Retrieved on: 
Tuesday, August 3, 2021
Articles, Communication, Forward-looking statement, Philosophy, Causality, Auditing, Financial statements

DALLAS, Aug. 3, 2021 /PRNewswire/ -- CECO Environmental Corp. (Nasdaq: CECE) today announced that its Board of Directors has authorized a share repurchase program under which CECO may purchase up to $5 million of its outstanding common shares through December 31, 2021.

Key Points: 
  • These statements are made on the basis of management's views and assumptions regarding future events and business performance.
  • We use words such as "believe," "expect," "anticipate," "intends," "estimate," "forecast," "project," "will," "plan," "should" and similar expressions to identify forward-looking statements.
  • Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
  • Potential risks and uncertainties, among others, that could cause actual results to differ materially are discussed under "Part I Item 1A.

Synthetic Biologics Expands Option for an Exclusive License Agreement with Massachusetts General Hospital

Retrieved on: 
Tuesday, August 3, 2021
Life sciences, Biotechnology, Health sciences, Hepatitis, Non-alcoholic fatty liver disease, Biopharmaceutical, Liver

Synthetic Biologics previously announced an option agreement with MGH to negotiate an exclusive license to IP and technology for the use of SYN-020 to prevent and treat metabolic and inflammatory diseases associated with aging.

Key Points: 
  • Synthetic Biologics previously announced an option agreement with MGH to negotiate an exclusive license to IP and technology for the use of SYN-020 to prevent and treat metabolic and inflammatory diseases associated with aging.
  • The option agreement has now been expanded to include technology developed by MGH to use SYN-020 to inhibit liver fibrosis in select diseases, including NAFLD.
  • Under the terms of the amended agreement, Synthetic Biologics is granted an option to negotiate an exclusive worldwide license with MGH to commercially develop SYN-020 to treat and prevent metabolic and inflammatory diseases associated with aging and fibrosis of the liver.
  • Synthetic Biologics recently announced the completion of patient dosing and observation of its Phase 1 single-ascending dose ("SAD") clinical trial of SYN-020 in 24 healthy adult volunteers.

Xos Registration Statement Related to Business Combination With NextGen Acquisition Corporation Declared Effective by SEC

Retrieved on: 
Friday, July 30, 2021
Alternative Vehicles, Fuels, Trucking, Finance, Automotive, Transport, Automotive Manufacturing, Professional services, Manufacturing, Fleet management, Finance, Money, Corporate finance, Private equity, Special-purpose acquisition company, XOS, NASDAQ, Financial markets, NextGen Healthcare

NextGen Acquisition Corporation (NASDAQ:NGAC) (NextGen) today announced its Registration Statement on Form S-4 in connection with the previously announced business combination (the Business Combination) with Xos, Inc. ("Xos" or the "Company"), a leading manufacturer of fully electric Class 5 to Class 8 commercial vehicles, has been declared effective by the Securities and Exchange Commission (the SEC).

Key Points: 
  • NextGen Acquisition Corporation (NASDAQ:NGAC) (NextGen) today announced its Registration Statement on Form S-4 in connection with the previously announced business combination (the Business Combination) with Xos, Inc. ("Xos" or the "Company"), a leading manufacturer of fully electric Class 5 to Class 8 commercial vehicles, has been declared effective by the Securities and Exchange Commission (the SEC).
  • The boards of directors of Xos and NextGen have unanimously approved the Business Combination.
  • NextGen Acquisition Corporation is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
  • Neither Xos nor NextGen gives any assurance that either Xos or NextGen, or the combined company, will achieve its expectations.

Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021

Retrieved on: 
Friday, July 30, 2021
Biotechnology, Pharmaceutical, Health, Acorda Therapeutics, Life sciences, Industry economics), Biotechnology

Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its second quarter 2021 update and financial results on Thursday, August 5 at 4:30 p.m.

Key Points: 
  • Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its second quarter 2021 update and financial results on Thursday, August 5 at 4:30 p.m.
  • For the Webcast, you will receive an email 2 hours prior to the start of the call with the link to join.
  • The archived webcast will be available in the Investor Relations section of the Acorda website at www.acorda.com .
  • Acorda Therapeutics develops therapies to restore function and improve the lives of people with neurological disorders.

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

Retrieved on: 
Friday, July 30, 2021
Consulting, Banking, Professional services, Finance, BlackRock, Economy of New York City, Companies, Finance

No conclusions should be drawn about BKTs investment performance from the amount of the Funds distributions or from the terms of the Funds Plan.

Key Points: 
  • No conclusions should be drawn about BKTs investment performance from the amount of the Funds distributions or from the terms of the Funds Plan.
  • The amount distributed per share under a Plan is subject to change at the discretion of the applicable Funds Board.
  • The amendment or termination of a Plan could have an adverse effect on the market price of the Fund's shares.
  • For additional information on BlackRock, please visit www.blackrock.com/corporate | Twitter: @blackrock | LinkedIn: www.linkedin.com/company/blackrock
    BlackRock will update performance and certain other data for the Funds on a monthly basis on its website in the Closed-end Funds section of www.blackrock.com as well as certain other material information as necessary from time to time.

Renowned Female Entrepreneurs Bobbi Brown and Rebecca Minkoff Join TriNet PeopleForce Roster of Distinguished Speakers

Retrieved on: 
Monday, August 2, 2021
Mental health, Cosmetics, BBC 100 Women, Bobbi Brown, Bobbi, TriNet, Psychological resilience, TriNet, Articles

DUBLIN, Calif., Aug. 2, 2021 /PRNewswire/ -- TriNet, a leading provider of comprehensive human resources for small and medium-size businesses (SMBs), today announced the addition of Bobbi Brown, makeup artist, entrepreneur and best-selling author, and Rebecca Minkoff, leading fashion designer and best-selling author, to its roster of well-known business leaders, thought leaders and influencers at the 2nd annual, award-winning, TriNet PeopleForce 2021. The four-day conference will be held in-person from The Times Center in New York City (built by renowned architect Renzo Piano) and virtually from anywhere. It kicks off on September 13 with an impressive roster of distinguished speakers sharing timely and insightful content vital to business success and the future of work.

Key Points: 
  • It kicks off on September 13 with an impressive roster of distinguished speakers sharing timely and insightful content vital to business success and the future of work.
  • Through their individual sessions, both Brown and Minkoff will share inspiring stories of entrepreneurship, resilience and perseverance with business leaders attending TriNet PeopleForce.
  • Brown revolutionized the beauty industry when she introduced Bobbi Brown Essentials in 1991, which were cosmetics designed to highlight a woman's natural look.
  • The Este Lauder Companies acquired Bobbi Brown Cosmetics in 1995, where Brown served as Chief Creative Officer until she departed in 2016.

Universal Technical Institute Reports Fiscal Year 2021 Third Quarter Results

Retrieved on: 
Monday, August 2, 2021
Automotive industry in the United States, Universal Technical Institute, Vocational education in the United States, NASCAR, MMI, Mechanics' Institutes, Sports in the United States, Organizations, Sports

Management will hold a conference call to discuss the financial results for the fiscal 2021 third quarter ended June 30, 2021, on Monday, August 2, 2021, at 4:30 p.m.

Key Points: 
  • Management will hold a conference call to discuss the financial results for the fiscal 2021 third quarter ended June 30, 2021, on Monday, August 2, 2021, at 4:30 p.m.
  • A live webcast of the call will be available via the Universal Technical Instituteinvestor relations website at https://investor.uti.edu .
  • UTI discloses these non-GAAP financial measures because it believes that they provide investors an additional analytical tool to clarify its results of operations and identify underlying trends.
  • Through its network of 12 campuses nationwide, UTI offers post-secondary programs under the banner of several well-known brands, including Universal Technical Institute (UTI), Motorcycle Mechanics Institute and Marine Mechanics Institute (MMI) and NASCAR Technical Institute (NASCAR Tech).